Tuesday, November 12, 2019 10:32:44 PM
OneQor doing private labels, so OneQor in negotiations with companies like GNC and Monster Energy and things like that".
OneQor talking to several, a lot of CPG companies, consumer packaging companies, that don’t necessarily want us to manufacture for them, but want our proprietary formulations. We call those APIs, we call those Active Pharmaceutical Ingredients. And then the fourth would be pharma, and that’s over the counter and behind the counter prescriptions. So those are really my four revenue drivers for the organization. And white labels currently doing very well I think, this is my third month that I’ll be at two and a half million in revenue in my third month. Info from MM interview:
https://foundr.com/matthew-morgan-reef-dispensary-oneqor#transcript
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM